Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Rheumatology and Therapy|July 8, 2024
A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDsLouis Bessette, Brandusa Florica, Latha Naik, et al.
Rheumatology (Oxford, England)|August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 yearsJanet Pope, Louis Bessette, Niall Jones, et al.
Advances in Rheumatology (London, England)|August 6, 2024
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort studyWen Qi, Antoine Robert, Narcisse Singbo, et al.
The Journal of Rheumatology|March 2, 2022
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV TrialsLouis Bessette, Eduardo Mysler, Cassandra D Kinch, et al.
Advances in Rheumatology (London, England)|June 24, 2026
CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-worldJanet E Pope, John S Sampalis, Boulos Haraoui, et al.
BMC Rheumatology|November 29, 2021
Expectations and educational needs of rheumatologists, rheumatology fellows and patients in the field of precision medicine in Canada, a quantitative cross-sectional and descriptive studySophie Ruel-Gagné, David Simonyan, Jean Légaré, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 20, 2012
Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal womenSonia Jean, Louis Bessette, Etienne L Belzile, et al.
Rheumatology and Therapy|March 12, 2024
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP StudyLouis Bessette, Jonathan Chan, Andrew Chow, et al.
Contemporary Clinical Trials|September 4, 2007
Recognizing osteoporosis and its consequences in Quebec (ROCQ): background, rationale, and methods of an anti-fracture patient health-management programmeLouis Bessette, Louis-Georges Ste-Marie, Sonia Jean, et al.
Rheumatology International|February 8, 2025
The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort studyWilliam Berthelot, Caroline Sirois, Anne-Sophie Julien, et al.
Pageof 12